Compare Enzyme (MLN) vs Succinct (PROVE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Succinct — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Succinct trades at Rp3,594 (market cap Rp700,73M, Rp89,77M 24h volume). The key difference: Succinct is far larger — about 5.2× Enzyme's market cap, and Succinct's supply is capped (195M / 1B PROVE (20%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Succinct for 23 Days on average.
| MLN | PROVE | |
|---|---|---|
Market Cap | Rp134,13M | Rp700,73M |
Volume (24h) | Rp104,56M | Rp89,77M |
Circulating Supply | 3,3M MLN | 195M / 1B PROVE (20%) |
Typical Hold Time | 28 Days | 23 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows modest market activity with a market cap of Rp134.13 million and circulating supply of 3.3 million tokens. The asset demonstrates typical cryptocurrency volatility patterns with a 28-day average hold time indicating moderate trader engagement. Recent market data shows limited trading volume and liquidity depth across exchanges.
Overall outlook remains cautious with opportunities in protocol utility but significant risks from low liquidity and market volatility. Investors should monitor exchange listings and on-chain activity for improved market participation while being aware of the asset's limited trading infrastructure and regulatory uncertainties.
PROVE is currently trading at Rp3,596 with a bearish technical signal, showing mixed momentum indicators. The token has a market cap of Rp697.62 million with 20% of its 1 million max supply in circulation. Current price sits between key support at Rp3,573 and resistance at Rp3,681, with RSI_6 at 27.42 suggesting potential oversold conditions. No major protocol updates or ecosystem developments were identified in recent analysis.
Overall outlook remains cautious with bearish technical pressure but potential for short-term bounce from oversold levels. Key opportunities include accumulation near support zones, while risks include low liquidity and limited market depth. Investors should monitor for any protocol developments that could drive adoption.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Succinct
Succinct is a protocol designed for verifiable computation, allowing developers to easily create and verify zero-knowledge (ZK) proofs in various contexts using its general-purpose zero-knowledge virtual machine (zkVM). Its mission is to establish cryptographic verifiability as a standard feature in blockchain, Web3 infrastructure, and beyond. This initiative aims to enhance the scalability, security, and trust-minimization of systems.
Read more on PROVE →
